Gemphire Therapeutics Inc. Purchase Agreements

9 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Securities Purchase Agreement between MetaVia Inc. and Purchasers dated May 8, 2025
Purchase Agreements
Gemphire Therapeutics Inc.
Biotechnology
NY
2025
Securities Purchase Agreement between NeuroBo Pharmaceuticals, Inc. and Purchasers (June 23, 2024)
Purchase Agreements
Gemphire Therapeutics Inc.
Biotechnology
NY
2024
Securities Purchase Agreement between NeuroBo Pharmaceuticals, Inc. and Purchasers (June 23, 2024)
Purchase Agreements
Gemphire Therapeutics Inc.
Biotechnology
NY
2024
Securities Purchase Agreement between NeuroBo Pharmaceuticals, Inc. and Dong-A ST Co., Ltd. dated September 14, 2022
Purchase Agreements
Gemphire Therapeutics Inc.
Biotechnology
NY
2022
Securities Purchase Agreement between NeuroBo Pharmaceuticals, Inc. and Purchasers (October 1, 2021)
Purchase Agreements
Gemphire Therapeutics Inc.
Biotechnology
NY
2021
Securities Purchase Agreement between NeuroBo Pharmaceuticals, Inc. and Purchasers (January 18, 2021)
Purchase Agreements
Gemphire Therapeutics Inc.
Biotechnology
NY
2021
Securities Purchase Agreement between NeuroBo Pharmaceuticals, Inc. and Purchasers (April 13, 2020)
Purchase Agreements
Gemphire Therapeutics Inc.
Biotechnology
NY
2020
Acquisition Agreement Between Dong-A ST Co., Ltd. and NeuroBo Pharmaceuticals, Inc. (DA-9803)
Purchase Agreements
Gemphire Therapeutics Inc.
Biotechnology
DE
2019
Securities Purchase Agreement between Gemphire Therapeutics Inc. and Purchasers (March 10, 2017)
Purchase Agreements
Gemphire Therapeutics Inc.
Biotechnology
NY
2017